Business Context and Reporting Period
This Form 8-K was filed by Synaptogenix, Inc. (not TAO Synergies Inc.) on December 28, 2022, reporting events occurring on December 27, 2022. The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbol SNPX. The filing addresses a corporate governance amendment rather than financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a bylaw amendment and does not contain financial statements or operational metrics.
Material Changes
The primary material change reported is an amendment to the Company's Bylaws approved by the Board of Directors on December 27, 2022, which became effective immediately:
- Quorum Requirement: The quorum for stockholder meetings was reduced from a majority of outstanding shares to at least one-third of the issued and outstanding shares entitled to vote.
- Scope: This change applies to all meetings of stockholders, whether held in person or by proxy.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies were disclosed in this document other than the standard incorporation by reference of the full text of the Bylaw Amendment (Exhibit 3.1).
Key Facts for Investor Verification
- Verify the exact text of the Bylaw Amendment in Exhibit 3.1 to confirm the new one-third quorum threshold.
- Confirm the company name is Synaptogenix, Inc. (SNPX), as the metadata reference to "TAO Synergies Inc." appears to be incorrect based on the filing content.
- Note that this filing does not impact the company's financial position or operational results.